SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-044527
Filing Date
2018-07-10
Accepted
2018-07-10 17:24:51
Documents
3
Period of Report
2018-07-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-17103_18k.htm 8-K 45026
2 EX-99.1 a18-17103_1ex99d1.htm EX-99.1 10780
3 GRAPHIC g171031mmi001.jpg GRAPHIC 3113
  Complete submission text file 0001104659-18-044527.txt   61542
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 18947620
SIC: 2836 Biological Products, (No Diagnostic Substances)